Issue No. 601/602 (16 September -15 October 2015)
WTO members split over Nairobi outcome, post-Nairobi programme

*Click on cover to download (PDF)

General Council meet shows WTO members sharply divided
Ahead of the WTO’s 10th Ministerial Conference, to be held in Nairobi in December, member states remain far apart on what is to be decided at the meeting as well as what will happen to the Doha Round negotiations after Nairobi.
by D. Ravi Kanth

No binding commitments at Nairobi on LDC package, say developed countries
The WTO’s Nairobi meeting may deliver little in the way of credible and binding outcomes, with the developed countries appearing reluctant to make significant commitments on this front, as the following two reports on recent discussions among trade envoys indicate.
by D. Ravi Kanth

US wants S&DT for its non-compliance on export competition pillar
by D. Ravi Kanth

Less than half of total to bring TFA into force
The WTO’s new Trade Facilitation Agreement has so far secured only under half the number of ratifications required for it to come into force, making it unlikely that the treaty will take effect by the time of the Nairobi Ministerial Conference.
by Kanaga Raja

US offer on LDC transition period “indefensible”, say NGOs
Civil society groups have slammed as inadequate a US proposal for a 10-year waiver from intellectual property protection for pharmaceuticals in the world’s least developed countries, saying the waiver should instead be in force for as long as these countries remain LDCs.
by Sangeeta Shashikant

EU commitment on access to drugs is an “empty gesture”
The EU’s continued push for strict intellectual property standards that threaten the availability of affordable generic drugs is not in keeping with its stated commitment to promote access to medicines, say two international health advocacy groups.
by Kanaga Raja

Rights expert recommends new IP regime for pharmaceuticals
Pointing to concerns that intellectual property laws may undermine the enjoyment of human rights, including the right to science and culture, a UN rights expert has called, among others, for a new intellectual property regime for pharmaceutical products that is consistent with rights law and public health needs.
by K.M. Gopakumar

World economy to grow by 2.5% this year, says UNCTAD
Global economic growth this year is projected to be 2.5%, according to the United Nations Conference on Trade and Development (UNCTAD) – much the same as in 2014 but significantly below the pre-crisis level. In its Trade and Development Report 2015, UNCTAD looks at how different regions of the world economy are expected to fare and considers whether the lower post-crisis growth trajectories reflect a “secular stagnation” in developed countries.
by Kanaga Raja

UN manipulated by TNCs, study charges
The UN is increasingly turning to the business sector for funding and collaboration, says a recent study, putting at risk its reputation and democratic governance.
by Thalif Deen

Opinion: Protracted stagnation threatens solidarity, development
If the UN’s newly adopted post-2015 development agenda is to be fulfilled, a more ambitious and reinvigorated global partnership for sustainable development is required, write Jomo Kwame Sundaram and Rob Vos.

Opinion: The party’s over for the Sustainable Development Goals
The UN must go beyond business-as-usual in order to realize its Sustainable Development Goals – and poor people around the world are showing the way.
by Adriano Campolina

Opinion: TPP raises the barriers to access to affordable medicines
New trade treaties like the Trans-Pacific Partnership are ratcheting up already high levels of intellectual property protection to the benefit of big pharmaceutical corporations from the US and the EU.
by Carlos M. Correa